DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Toluene is an investigational drug.
There have been 9 clinical trials for Toluene. The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2009.
The most common disease conditions in clinical trials are Leukemia, Carcinoma, Hepatocellular, and Melanoma. The leading clinical trial sponsors are National Cancer Institute (NCI), PTS International Inc., and First Affiliated Hospital of Zhejiang University.
Recent Clinical Trials for Toluene
|Treatment of Non-small Cell Lung Cancer With PD-1 Monoclonal Antibody Combined With Donafenib Toluene Sulfonate||First Affiliated Hospital of Zhejiang University||Phase 1|
|A Phase II Study of PTS100 in Primary HCC Patients||Gongwin Biopharm Co., Ltd.||Phase 2|
|A Study of PTS for Patients With Solid Tumors||PTS International Inc.||Phase 1|